PROVIDER PROFILE · NPI 1225357726

Geeta Varghese

Internal MedicineNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

702

Beneficiaries

—

Total drug cost

$101K

Distinct drugs

Brand share

21.4%

Top prescribed drugs

Atorvastatin Calcium150 claims

Metformin Hcl51 claims

Amlodipine Besylate47 claims

Omeprazole47 claims

Losartan Potassium46 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Geeta Varghese's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
BETH ISRAEL MEDICAL CENTER	57	222
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	38	74
Betsy Varghese Internal Medicine · Livingston, NJ	15	20

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
WILLIAM F. RYAN COMMUNITY HEALTH CENTER INC	134	290
BETH ISRAEL MEDICAL CENTER	40	147
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	21	33
Alan Tso Internal Medicine · Newark, NJ	12	21
Betsy Varghese Internal Medicine · Livingston, NJ	11	18

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history